Christopher Lieu, MD, was a panel moderator at this year's NCCN 2026 Annual Conference, where he spoke about the importance of multidisciplinary care when it came to responding to the rise in cancer incidence in people under 50: https://bit.ly/3QkDlkQ
CU Anschutz Cancer Center research presented at #ASPO2026 says fear-based images, graphic depictions of diseased lungs, ominous warnings, and blame-focused language may discourage participation in lung cancer screening ⬇️
news.cuanschutz.edu/cancer-center/reframing-...
In her leadership, Lia Gore, MD, creates space for diverse perspectives, recognizing that the best solutions come from shared ideas.
Full interview: youtu.be/PtQ7DPwgwG0?...
When winter and spring collide! ❄️ 🌸
In this Q&A, CU Anschutz Cancer Center's Sachin Wani, MD, breaks down the symptoms of "silent reflux" and when it may be time to seek out specialized care: news.cuanschutz.edu/medicine/silent-reflux-c...
A photo cutout of a female doctor talking to a female patient. There is a line pointing to the doctors notes. The line starts from a circle framed photo of an X-Ray image of lungs. The background is a white on top and CU gold on the bottom.
Breast cancer hijacks the lung repair system to fuel tumor growth, CU Anschutz Cancer Center researchers find: https://bit.ly/3NGY01H
Tin Tin Su, PhD, believes in following the data wherever it leads. Instead of fearing unexpected results, she embraces them as opportunities to learn, adapt, and discover something new.
Watch the full interview: youtu.be/U1KjNDA7eRs?...
On a mostly white background there is a CU dark gray rectangle with CU gold text "SECOND ANNUAL INTERNATIONAL ROCKY MOUNTAIN PANCREATIC CANCER SYMPOSIUM". Then in black text "April 30, 2026, 8:00 a.m. - 5:00 p.m. RMLEI Auditorium, UCHealth Sue Anschutz-Rodgers Eye Center. Featuring: International Perspectives on Pancreatic Cancer - Research, Diagnosis and Surgical Innovation". There is a CU gold triangle with two black lines bordering it. Between the two black lines it's CU light gray.
Learn about the latest advancements in pancreatic cancer research, diagnosis, and surgical innovation! RSVP for the Second Annual International Rocky Mountain Pancreatic Cancer Symposium on April 30: https://bit.ly/3Od7EsT
A man holding his upper chest and shoulder area. There is a line to a circle with a photo of x-ray image which highlights the esophagus. The background is black and CU gold. The black is on top and the gold is on the bottom.
#EsophagealCancerAwarenessMonth:
Researchers have developed a new AI tool with a 90% accuracy rate to predict Barrett’s Esophagus recurrence after therapy: https://bit.ly/4c8wzG4
In bold large black text "Fund the Fight Against Cancer" with a line breaking it up from the next set of text "and you could win a Jeep Grand Cherokee L Limited 4x4! Raffle from Cancer League of Colorado. Tickets $50 each or 3 for $125. Drawing 5/2." There is a cutout photo of a black Jeep Grand Cherokee L Limited 4x4. There is a CU light gray banner on the bottom of the graphic. In the bottom right is the Cancer League of Colorado logo.
Help fund cancer research, clinical trials, and services here in Colorado. And you could win a 2026 Jeep Grand Cherokee L Limited 4x4! Learn more about this Cancer League of Colorado raffle here: https://cancerleagueraffle-org.3dcartstores.com/
Opening remarks at the DT & MCO Joint Retreat.
Marcus Richards with their poster "Toxic Effects of Lead, Cadmium, and Arsenic Combinations in Drosophila."
Minami Hamelitz-Urena with their poster "Reconstitution and Structural Characterization of MacroH2A-containg Nucleosome Arrays".
Ben Bitler speaking at the DT & MCO Joint Retreat.
Yesterday's joint scientific retreat between the Developmental Therapeutics and Molecular and Cellular Oncology Programs highlighted how these two programs collaborate to advance basic science to translational discovery and implementation. 🔬
Enrique Soto Perez de Celis, MD, PhD, with geriatric clinic members Sophie Clark, MD, and Elizaveta Pchelko, BS, BA.
Overseen by CU Anschutz Cancer Center leader Enrique Soto Perez de Celis, MD, PhD, the CU Anschutz Geriatric Oncology Clinic helps older patients who need specialized care ⬇️
news.cuanschutz.edu/cancer-center/geriatric-...
Sunnie Kim, MD, and Cheryl Meguid, DNP, NP, during a Q&A.
Sachin Wani, MD, welcoming everyone to the event.
Two colleagues smiling for the camera near a poster.
Paul and Katy Rady speaking.
At the seventh annual Paul R. O’Hara II Esophagogastric Symposium, over 70 participants learned about the innovations in esophageal cancer screening, research, and treatment. 💜
PhD student at @cuanschutz.bsky.social, Samuel Burciaga, and his team are refining CAR-T cell therapies through the exploration of how immune cells can be engineered to be more effective at targeting cancer ⬇️
https://bit.ly/4sH76L1
A cutout photo of a women stretching while sitting in a chair. The women is facing away from the camera. There is a CU gold rectangle in the middle and it stretches to the left. There is a grid behind the rectangle and it stretches to the right.
Research from CU Anschutz Cancer Center's Heather Leach, PhD, and Rebecca Scalzo, PhD, shows that breast cancer survivors who are receiving selective estrogen receptor modulators may reduce their risk of diabetes by taking more breaks from sitting: https://bit.ly/4sGeupR
Head and Neck Cancer Awareness Month: Jessica McDermott, MD, raises awareness of HPV, which has become an increasingly prevalent risk factor for head and neck cancers: https://bit.ly/3TRmmG7
A cutout photo of Becky Grubb on a CU gold square with a black grid. There is a CU gray rectangle in the bottom right with a black and white ribbon. In the top left is a small photo of patient arms being held by a doctor.
Becky Grubb credits the CU Anschutz Cancer Center’s multidisciplinary care and clinical trials – plus a ‘huge village’ of support – for her quality of life after a stage IV colorectal cancer diagnosis: https://bit.ly/3PHzjTp
This white graphic has CU gold grids in each corner. In the blank space in the center in black text it reads "What Research Is Focusing On Next" and "Better ways to track cancer and responses to therapy, such as blood tests circulating tumor DNA and urine tests. Who truly needs treatment after surgery and who may be able to avoid extra therapy with a good response. Optimizing bladder‑preserving approaches for selected patients."
(6/6)
At the top there is a photo of a patient and doctor talking in an office. The photo is bordered by CU gold and dark gray bars. To the bottom in black text "Clinical Trials at CU Anschutz Cancer Center. We’re continuously offering multiple bladder cancer clinical trials — giving patients access to innovative therapies that go beyond traditional treatment and may lead to remission or longer life."
(5/6)
In black text "Multidisciplinary Bladder Cancer Care. Our dedicated clinic brings together experts in pathology, imaging, urologic oncology, medical oncology, and radiation oncology to provide each patient with a comprehensive, personalized care plan." Below the text is a photo of a person hold a paper diagram of a bladder. The photo is bordered with CU gold and gray bars.
(4/6)
A list of years for Key Immunotherapy Approvals For Bladder Cancer. 2016 Atezolizumab (mUC). 2017 Pembrolizumab (mUC). 2020 Pembrolizumab (NMIBC). 2023 Enfortumab Vedotin (EV) + Pembrolizumab (mUC). 2025 Durvalumab + Gemcitabine/Cisplatin (MIBC), EV + Pembrolizumab.
(3/6)
This graphic has a photo of Thomas Flaig, MD, over a CU gold grid in the bottom right corner. There is also a grid design in the top left and CU gold angle that starts in the bottom right. The following text is centered in the top: "New Treatment Options Showing Promise for Bladder cancer." Then in more text more to the center "Durvalumab + Bladder Renewal: Given with chemotherapy before and after surgery (“sandwich” approach). Helps delay the cancer from coming back and improves outcomes. EV + Pembrolizumab (for patients who can’t take cisplatin): Given before and after bladder removal surgery. Led to much higher response rates in early results, including more patients having no cancer detected at surgery."
Learn more about our bladder cancer research and clinical trials: bit.ly/3k8dr0B
(2/6)
A portrait photo of Thomas Flaig, MD. He is smiling. Towards the bottom there is a white shadow. On the white shadow in black text "NCCN Updates For Muscle Invasive Bladder Cancer". Below that text is a CU gold rectangle with black text "With Thomas Flaig, MD, Vice Chancellor for Research and cancer center member"
Thomas Flaig (@tomflaigmd.bsky.social), MD, Vice Chancellor for Research at CU Anschutz, continues to lead global bladder cancer treatment guidelines through his role at NCCN.
At the NCCN Annual Conference, he outlined new therapies, research, and practical insights to improve patient care. (1/6)
#NationalDoctorsDay: To prevent and conquer cancer together, it wouldn't be possible without our doctors. Thank you for all that you do! 💛 🖤
Cathy Bradley, PhD, CU Anschutz Cancer Center deputy director and dean of the Colorado School of Public Health, shares the importance of the Colorado Cancer Screening Program. Learn more: https://bit.ly/4aSeQC2
"As soon as they told me about this trial, I said, ‘I’m all in,’” said Teresa Anne Volgenau about a clinical trial overseen by Stacy Fischer, MD, which is evaluating the effectiveness of the psychedelic drug psilocybin and talk therapy ⬇️
https://bit.ly/4bIBMEj
As part of an international study, Nikita Pozdeyev, MD, and Christopher Gignoux, PhD, uncovered previously-unknown genetic variants linked to thyroid cancer, along with clues to predict the cancer’s aggressiveness ⬇️
https://bit.ly/4t6uvFh
Colorectal Cancer Awarness Month: Swati Patel, MD, points to exciting developments, including vaccines and clinical trials, to help people with Lynch syndrome avoid cancer ⬇️
news.cuanschutz.edu/cancer-center/lynch-synd...
A graphic with the following text: "7TH ANNUAL: Paul R. O’Hara II Esophagogastric Symposium. April 4, 2026, 8:00 a.m. - 1:30 p.m. Donald M. Elliman Conference Center, CU Anschutz Health Sciences Building. Hear from providers, keynote speakers, researchers, and network with attendees. Topics include screening, treatment strategies, and more." On the right side with a a CU gold line, is a close up photo of the windows of the Anschutz Health Sciences Building.
Last chance to register for the Seventh Annual Paul R. O'Hara II Esophagogastric Cancer Symposium. Gain comprehensive knowledge of esophagogastric conditions, including screening guidelines, treatment strategies, and more! Register here: https://bit.ly/4t25ond
Enrique Soto Pérez de Celis, MD, PhD, a geriatric oncology specialist, recently took up the challenge of finding a better path forward for this older group of patients facing both cancer and loneliness ⬇️
news.cuanschutz.edu/news-stories/treating-lo...
